Eight EU-funded research consortia warn that Europe risks a crisis if it fails to halt pollinator loss. Their solution: a roadmap to reverse wild pollinator decline and protect managed bees.

The United States still leads China in the quality and commercial reach of its biomedical science but is losing the race to translate scientific discoveries into cures. New analyses from the Cure Innovation Index, released today ahead of Cure's session on U.S.-China biomedical competitiveness at the BIO International Convention in San Diego, find that without immediate renewed investment and policy changes, the U.S. scientific edge will not hold. “America’s challenge is no longer discovery alone. The emerging battleground is translation, the speed and efficiency with which scientific breakthroughs move from the laboratory into development, commercialization, and patient impact," said Seema Kumar, CEO of Cure, the premier healthcare innovation ecosystem headquartered in New York City. If the United States wants to stay ahead, the answer isn't to out-publish China. It's to fix the translational bottlenecks with renewed funding, especially for early translational work, modernized clinical trial infrastructure, and stronger bridges between academic research and industry.

The recent suspension of Anthropic’s Mythos and Fable models brings the conflict between AI innovation and safety into public view: some favor innovation prohibitions while others are skeptical of safety constraints. A new paper in Law, Ethics and Technology by philosopher James Brusseau resolves the dilemma with “acceleration AI ethics,” a framework for answering AI risks with further innovation. Using the Telus GenAI customer support agent as a case study, the article argues that responsible AI does not have to choose between moving fast and advancing safely. Instead, the safety risks generated by innovation are overcome by the same innovative forces that created them.

Tapping into the power of collaboration, Johns Hopkins University and West Virginia University are launching a new partnership to bring together researchers from both institutions to address complex challenges in health, science and society while positioning faculty teams to compete for future external funding.